These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 24158091)
1. Mining clinical text for signals of adverse drug-drug interactions. Iyer SV; Harpaz R; LePendu P; Bauer-Mehren A; Shah NH J Am Med Inform Assoc; 2014; 21(2):353-62. PubMed ID: 24158091 [TBL] [Abstract][Full Text] [Related]
2. Discovering clinical drug-drug interactions with known pharmacokinetics mechanisms using spontaneous reporting systems and electronic health records. Jeong E; Su Y; Li L; Chen Y J Biomed Inform; 2024 May; 153():104639. PubMed ID: 38583580 [TBL] [Abstract][Full Text] [Related]
3. Learning signals of adverse drug-drug interactions from the unstructured text of electronic health records. Iyer SV; Lependu P; Harpaz R; Bauer-Mehren A; Shah NH AMIA Jt Summits Transl Sci Proc; 2013; 2013():98. PubMed ID: 24303244 [TBL] [Abstract][Full Text] [Related]
4. Learning signals of adverse drug-drug interactions from the unstructured text of electronic health records. Iyer SV; Lependu P; Harpaz R; Bauer-Mehren A; Shah NH AMIA Jt Summits Transl Sci Proc; 2013; 2013():83-7. PubMed ID: 24303305 [TBL] [Abstract][Full Text] [Related]
5. An Integrative Data Science Pipeline to Identify Novel Drug Interactions that Prolong the QT Interval. Lorberbaum T; Sampson KJ; Woosley RL; Kass RS; Tatonetti NP Drug Saf; 2016 May; 39(5):433-41. PubMed ID: 26860921 [TBL] [Abstract][Full Text] [Related]
6. Propensity score-adjusted three-component mixture model for drug-drug interaction data mining in FDA Adverse Event Reporting System. Wang X; Li L; Wang L; Feng W; Zhang P Stat Med; 2020 Mar; 39(7):996-1010. PubMed ID: 31880829 [TBL] [Abstract][Full Text] [Related]
7. Mining Directional Drug Interaction Effects on Myopathy Using the FAERS Database. Chasioti D; Yao X; Zhang P; Lerner S; Quinney SK; Ning X; Li L; Shen L IEEE J Biomed Health Inform; 2019 Sep; 23(5):2156-2163. PubMed ID: 30296244 [TBL] [Abstract][Full Text] [Related]
8. Feasibility of Prioritizing Drug-Drug-Event Associations Found in Electronic Health Records. Banda JM; Callahan A; Winnenburg R; Strasberg HR; Cami A; Reis BY; Vilar S; Hripcsak G; Dumontier M; Shah NH Drug Saf; 2016 Jan; 39(1):45-57. PubMed ID: 26446143 [TBL] [Abstract][Full Text] [Related]
9. Mining and visualizing high-order directional drug interaction effects using the FAERS database. Yao X; Tsang T; Sun Q; Quinney S; Zhang P; Ning X; Li L; Shen L BMC Med Inform Decis Mak; 2020 Mar; 20(Suppl 2):50. PubMed ID: 32183790 [TBL] [Abstract][Full Text] [Related]
10. Detection of drug-drug interactions through data mining studies using clinical sources, scientific literature and social media. Vilar S; Friedman C; Hripcsak G Brief Bioinform; 2018 Sep; 19(5):863-877. PubMed ID: 28334070 [TBL] [Abstract][Full Text] [Related]
12. DDIWAS: High-throughput electronic health record-based screening of drug-drug interactions. Wu P; Nelson SD; Zhao J; Stone CA; Feng Q; Chen Q; Larson EA; Li B; Cox NJ; Stein CM; Phillips EJ; Roden DM; Denny JC; Wei WQ J Am Med Inform Assoc; 2021 Jul; 28(7):1421-1430. PubMed ID: 33712848 [TBL] [Abstract][Full Text] [Related]
13. Mining association patterns of drug-interactions using post marketing FDA's spontaneous reporting data. Ibrahim H; Saad A; Abdo A; Sharaf Eldin A J Biomed Inform; 2016 Apr; 60():294-308. PubMed ID: 26903152 [TBL] [Abstract][Full Text] [Related]
14. Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy. Leone R; Magro L; Moretti U; Cutroneo P; Moschini M; Motola D; Tuccori M; Conforti A Drug Saf; 2010 Aug; 33(8):667-75. PubMed ID: 20635825 [TBL] [Abstract][Full Text] [Related]
15. Identification of adverse drug-drug interactions through causal association rule discovery from spontaneous adverse event reports. Cai R; Liu M; Hu Y; Melton BL; Matheny ME; Xu H; Duan L; Waitman LR Artif Intell Med; 2017 Feb; 76():7-15. PubMed ID: 28363289 [TBL] [Abstract][Full Text] [Related]
16. Mining heterogeneous networks with topological features constructed from patient-contributed content for pharmacovigilance. Yang CC; Yang H Artif Intell Med; 2018 Aug; 90():42-52. PubMed ID: 30093253 [TBL] [Abstract][Full Text] [Related]
17. Coupling Data Mining and Laboratory Experiments to Discover Drug Interactions Causing QT Prolongation. Lorberbaum T; Sampson KJ; Chang JB; Iyer V; Woosley RL; Kass RS; Tatonetti NP J Am Coll Cardiol; 2016 Oct; 68(16):1756-1764. PubMed ID: 27737742 [TBL] [Abstract][Full Text] [Related]
18. A reference set of clinically relevant adverse drug-drug interactions. Kontsioti E; Maskell S; Dutta B; Pirmohamed M Sci Data; 2022 Mar; 9(1):72. PubMed ID: 35246559 [TBL] [Abstract][Full Text] [Related]
19. Mixture drug-count response model for the high-dimensional drug combinatory effect on myopathy. Wang X; Zhang P; Chiang CW; Wu H; Shen L; Ning X; Zeng D; Wang L; Quinney SK; Feng W; Li L Stat Med; 2018 Feb; 37(4):673-686. PubMed ID: 29171062 [TBL] [Abstract][Full Text] [Related]
20. Automatic signal extraction, prioritizing and filtering approaches in detecting post-marketing cardiovascular events associated with targeted cancer drugs from the FDA Adverse Event Reporting System (FAERS). Xu R; Wang Q J Biomed Inform; 2014 Feb; 47():171-7. PubMed ID: 24177320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]